R.L. Merriman, et al., “Comparison of the Antitumor activity of Gemcitabine and Ara-C in a Panel of Human Breast, Colon, Ling and Pancreatic Xenograft Models”, Investigational New Drugs, vol. 14, (1996) pp. 243-247. |
W. Plnkett, et al., “Preclinical Characteristic of Gemcitabine”, Anti-Cancer Drugs, vol. 6, Suppl. 6, (1995) pp. 7-13. |
R. A. Schwendener, Liposomen als Träger vol lipophilen Cytosinarabinosid-und Fluorodeoxyuridin-Derivaten, Onkologie, vol. 10 (Apr. 1987) pp. 232-239 (English Abstract). |
R. Ohno, et al., “Treatment of Leukemia and Myelodysplastic Syndromes with Orally Administered N4-palmitoyl-1-β-D-arabimofuranosylcytosine”, Cancer Chemother. Pharmacol., vol. 17, (1986) pp. 161-164. |
W. Rubas, et al., “Treatment of Murine L1210 Lymphoid Leukemia and Melanoma B16 with Lipophilic Cytosine Arabinoside Prodrugs Incorporated Into Unilamellar Liposomes”, Int. J. Cancer, vol. 37, (1986) pp. 149-154. |
R.A. Schwendener, et al., “Liposomes as Carries for Lipophilic Antitumor Prodrugs. Incorporation Characteristics and In Vivo Cytotoxic Activity”, Liposomes Drug Carries, Symp. (1986) Meeting Date 1984, pp. 170-181 (Abstract Only). |
Stedman's Medical Dictionary, 24th Edition, (1982) p. 817 (Baltimore, Md.). |
N. Kemeny, et al., “Phase II Study of 2,2'-Anhydro-1-β-D-arabinofuranosyl-5-fluorocytosine in Advanced Colorectal Carcinoma”, Cancer Treatment Reports, vol. 62, No. 3, (1978). |
G.P. Bodey, et al., “Clinical Studies of β-Thioguanine Deoxyriboside Alone and in Combination with Arabinosyl Cytosine”, Medical and Pediatric Oncology, vol. 2, (1976) pp. 199-205. |
E.K. Hamamura, et al., “Reactions of 2-Acyloxyisobutyryl Halides with Nucleosides. 8. Synthesis and Biological Evaluation of Some 3'-Acyl and 3', 5'-Diacyl Derivatives of 1-β-D-Arabinofuranosylcytosine”, Journal of Medicinal Chemistry, vol. 19, No. 5, (1976) pp. 667-674. |
J.G. Moffatt, et al., Synthesis and Biologic Examination of Some Derivatives of 2,2'-Anhydro-1-(β-D-arabinofuranosyl)cytosine Hydrochloride (NSC-145668), Cancer Chemotherapy Reports, Part 1, vol. 58, No. 4, (Jul./Aug. 1974) pp. 451-469. |
G.D. Gray, et al., “ImmunoSuppressive, Antiviral and Antitumor Activites of Cytarabine Derivatives”, Biochemical Pharmacology, vol. 21, pp. 465-475, Pergamon Press, 1972. |
D.T. Warner, et al., 'Nucleic Acids. 13.3'-O-and 2'-O-Esters of 1-β-D-Arabinofuranosylctosine as Antileukemic and Immunosuppressive Agents, Journal of Medicinal Chemistry, vol. 15, No. 8, (1972) pp. 790-792. |